Litigation
thumbnail
Supplement RegulationsQuincy Bioscience tells jurors it relied on FTC guidance in supporting claims for PrevagenQuincy Bioscience tells jurors it relied on FTC guidance in supporting claims for Prevagen
In a 7-year-old case that focused on the science behind Prevagen, jurors were introduced to the concept of “competent and reliable scientific evidence.” But Federal Trade Commission guidance only proved to be an important consideration for Quincy, not the state of New York.
Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.